Immunotech Biopharm Ltd (HKG:6978)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.260
+0.120 (2.90%)
Aug 7, 2025, 1:42 PM HKT
2.90%
Market Cap2.16B
Revenue (ttm)n/a
Net Income (ttm)-198.91M
Shares Out514.58M
EPS (ttm)-0.39
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume581,000
Average Volume475,200
Open4.140
Previous Close4.140
Day's Range4.140 - 4.300
52-Week Range1.500 - 6.150
Beta0.85
RSI62.87
Earnings DateAug 22, 2025

About Smartsheet

Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China. The company’s core product is EAL, a multi-target cellular immunotherapy product that is in Phase III clinical trials for the prevention of postsurgical recurrence of liver cancer. It also develops 6B11-OCIK injection that is in Phase I clinical trial for ovarian cancer; CAR-T-19 injection product for B-cell acute ... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 154
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6978
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.